Leveraging technology to address current and future world issues.

Biotechnology Global Health

Journal

Science translational medicine

ISSN: 1946-6242

Titre abrégé: Sci Transl Med

Pays: United States

ID NLM: 101505086

Informations de publication

Date de publication:
12 10 2022

Historique:

entrez: 12 10 2022

pubmed: 13 10 2022

medline: 15 10 2022

Statut: ppublish

Résumé

Biotechnology is essential to advance modern medicine and alleviate global health crises, yet commercialization is often wrought by competing forces.

Identifiants

DOI: 10.1126/scitranslmed.abq0606 PMID: 36223448

pubmed: 36223448

doi: 10.1126/scitranslmed.abq0606

doi:

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

Pagination

eabq0606

Auteurs

Ralph Weissleder (R)

Ralph Weissleder, Center for Systems Biology, Massachusetts General Hospital, 185 Cambridge St., CPZN 5206, Boston, MA 02114, USA. Department of Systems Biology, Harvard Medical School, 200 Longwood Ave, Boston, MA 02115, USA. Email: rweissleder@mgh.harvard.edu.

ORCID: 0000-0003-0828-4143

Classifications MeSH

questionsmedicales.fr › Technologie, industrie et agriculture › Technologie › Biotechnologie › Leveraging technology to address current and...

questionsmedicales.fr › Caractéristiques de la population › Santé › Santé mondiale › Leveraging technology to address current and...